No Data
No Data
No Data
No Data
No Data
Sector Update: Health Care Stocks Mixed Wednesday Afternoon
Health care stocks were mixed in Wednesday afternoon trading, with the NYSE Health Care Index fractionally higher and the Health Care Select Sector SPDR Fund (XLV) slightly lower. The iShares Biotechn
MT NewswiresApr 18 01:46
NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise
NeuroBo Pharmaceuticals (NRBO) said Wednesday the first patient has been dosed in part 1 of its two-part early-stage trial of DA-1726 for the treatment of obesity. The company said part 1 of the study
MT NewswiresApr 17 23:21
NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
Phase 1 Clinical Trial Timelines Significantly Accelerated Top-Line Data Readout from Single Ascending Dose Part 1 Now Expected in the Third Quarter of 2024 First Patient Dosed in the Multiple Ascend
PR NewswireApr 17 20:05
NeuroBo Pharmaceuticals Files For Mixed Shelf Offering Of Up To $150M
https://www.sec.gov/Archives/edgar/data/1638287/000155837024005018/tmb-20240412xs3.htm
BenzingaApr 13 04:13
NeuroBo Pharmaceuticals GAAP EPS of -$2.46
Seeking AlphaMar 29 03:02
NeuroBo Pharmaceuticals to Continue Trial of Liver Disease Treatment Candidate -- Shares Down
NeuroBo Pharmaceuticals (NRBO) said Wednesday it received the go-ahead to continue its mid-stage clinical trial of DA-1241 without modification, a treatment for metabolic dysfunction-associated steato
MT NewswiresMar 14 00:34
No Data
No Data